MAX Surgical Specialty Management Gains $77 Million Credit Boost

MAX Surgical Specialty Management Secures Major Financing
MAX Surgical Specialty Management, a leader in oral and maxillofacial surgery (OMS), has recently closed on a substantial $77 million senior credit facility. This financing is provided by Freeport Financial Partners, LLC, and will play a crucial role in facilitating the company's growth across the Northeast. It aims to empower MAX to forge new partnerships with top OMS practices in the region.
Strategic Growth and Partnerships
Mark Censoprano, Co-CEO of MAX, emphasized the importance of community connections in their expansion strategy. "Staying close to the communities we serve is at the heart of our partnership strategy," he stated. This injection of capital is designed to strategically enhance their presence across Northeast regions, ensuring that partnerships align with the community's healthcare needs.
The Latest Collaboration
In an exciting development, MAX has formed a partnership with Rothman and Kim Oral & Maxillofacial Surgery, a renowned practice in the Philadelphia area. Founded over 25 years ago by Drs. Marc Rothman and David Kim, this partnership marks a pivotal addition to MAX's network, having already established two locations.
Strengthening the Network
This partnership comes shortly after MAX welcomed Oral and Maxillofacial Surgery of Westfield into its network, led by Dr. Ronen Gold, renowned for his patient-first approach. Such collaborations augment MAX's presence in New Jersey and reinforce its reputation as a prominent OMS support platform, leading advancements in patient care across the region.
Rapid Expansion and Growth
MAX's network has seen remarkable growth since early 2024, adding 14 new practice locations and 17 surgeons to its roster in several states including New Jersey, New York, and Pennsylvania. This growth reflects a strategic focus on expanding their operational reach, nearly doubling their workforce to over 300 professionals. Such rapid expansion showcases MAX's forward-thinking approach to enhancing healthcare delivery.
Commitment to Excellence
According to Matt Gerdes, Managing Director at Freeport Financial Partners, this investment is a testament to the confidence in MAX's operational excellence and robust leadership team. He noted, "MAX's strong fundamentals and long-term value creation potential presented a compelling opportunity." This recognition underscores the significant potential that the company holds within the healthcare landscape.
Exceptional Leadership
Dr. Jason M. Auerbach, Founder and Co-CEO, also shared insights on the company’s mission. He highlighted that recruiting elite oral and maxillofacial surgeons who strive for excellence in patient care is a fundamental goal for MAX. The collaboration with established practices enhances this vision.
A Broad Reach for Quality Care
MAX now encompasses a concentrated network of OMS practices, which offers distinct advantages such as regional insights and strengthened relationships. This broader reach is significant to its operational strategy, ensuring high quality and accessible care to more patients.
About MAX Surgical Specialty Management
Established in 2022, MAX was developed to create a leading management services organization for oral and maxillofacial surgery in the Northeast. With a clear focus on surgeon autonomy and clinical excellence, MAX continually supports practices in New Jersey, New York, Pennsylvania, Vermont, and Connecticut. The organization is dedicated to empowering surgeons with resources and advancing the specialty through collaborative efforts.
Key Collaborators
MAX benefits from the backing of MedEquity Capital, RF Investment Partners, and Kian Capital, each playing a vital role in its strategic ambitions. Together, they represent a strong investment in the future growth and scalability of MAX's network.
Conclusion
With its recent financing and partnerships, MAX Surgical Specialty Management is positioned to expand its footprint significantly in the oral and maxillofacial surgery market. By fostering relationships that enhance patient care and leveraging its operational strengths, MAX is not only upholding its reputation but also paving the way forward for advancements in the field.
Frequently Asked Questions
What is MAX Surgical Specialty Management known for?
MAX focuses on providing management services for oral and maxillofacial surgery, promoting clinical excellence and surgeon autonomy.
How much financing did MAX recently secure?
MAX secured a $77 million senior credit facility to support its growth and partnership strategies.
Who are MAX's notable partners?
MAX has partnered with established practices like Rothman and Kim Oral & Maxillofacial Surgery and Oral and Maxillofacial Surgery of Westfield.
In which regions does MAX operate?
MAX operates primarily in the Northeast, including states like New Jersey, New York, and Pennsylvania.
What is the mission of MAX Surgical Specialty Management?
The mission of MAX is to provide exceptional support to oral and maxillofacial surgeons while focusing on advancing patient care and leading industry innovations.
About The Author
Contact Logan Wright privately here. Or send an email with ATTN: Logan Wright as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.